Altoida Medical Device (AMD) provides health care professionals objective measurements of cognitive performance, and is indicated for use as an adjunctive tool to aid in evaluation perceptual and memory function in patients 55 to 95 years old. AMD is a FDA class II medical device enabling:

Early screening for cognitive decline patterns specific for prognosis (at risk) or classification of Mild Cognitive Impairment.

Monitoring cognition through evaluating perceptual and memory function in personnel at risk or with Mild Cognitive Impairment/Prodromal Alzheimer’s Disease.

Product components: Altoida Medical Device package contains an Altoida-customized iPad with pre-configured Altoida iOS app and Web Dashboard Login. The app offers access to the battery of three tests.

Patient Measurement: After completing the test batteries (10-15’ required), the neurologist receives access to a full patient report via a web-based dashboard (both fully HIPAA compliant).